LEXINGTON, Ky., May 7 /PRNewswire-FirstCall/ -- Central Baptist
Hospital (CBH) is making a significant contribution to clinical research on
the prevention of strokes. CBH ranks second in the overall number of
participants recruited for the Carotid Revascularization Endarterectomy vs.
Stenting Trial (CREST).
Sponsored by the National Institute of Stroke and Neurological
Disorders (NINDS) of the National Institutes of Health (NIH) and the
University of Medicine and Dentistry of New Jersey (UMDNJ), CREST is a
randomized clinical trial to compare carotid endarterectomy -- a common
operation to treat a blockage, or narrowing, of the carotid artery -- with
the study procedure, carotid artery stenting. The trial compares the
effectiveness of both procedures in preventing stroke, heart attack and
death during the 30-day period immediately following either procedure.
Multiyear follow-up of individuals who are enrolled in the study also will
document the incidence of stroke on the same side of the brain as the
carotid artery that received the treatment.
Of the 120 hospitals throughout the United States and Canada recruiting
for the CREST study, Central Baptist Hospital ranks second (as of December
31, 2006) in the overall number of participants recruited for CREST since
July 2003, when the hospital was approved as a recruiting site. CBH also is
tied for second place for the number of CREST participants recruited in
The CBH multidisciplinary team working on CREST includes Dr. William
Brooks, neurosurgeon; Dr. Michael Jones, cardiologist; Dr. Timothy Coleman,
neurologist; Dr. David Kelley, neurologist; Linda Breathitt, a registered
nurse who is the primary research coordinator for the project; and Caroline
Rodgers, a registered nurse who is a research coordinator for the project.
SOURCE Central Baptist Hospital